Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $52.6300 (0.48%) ($51.7700 - $52.6850) on Mon. Dec. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.15% (three month average) | RSI | 38 | Latest Price | $52.6300(0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.5% a day on average for past five trading days. | Weekly Trend | BAX declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) BLOK(23%) VWO(13%) GLD(12%) XLE(11%) EMHY(10%) | Factors Impacting BAX price | BAX will decline at least -1.075% in a week (0% probabilities). VIXM(-11%) EWP(-11%) TLT(-8%) ONLN(-7%) TIP(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.075% (StdDev 2.15%) | Hourly BBV | -0.5 () | Intraday Trend | 0.8% | | | |
|
Resistance Level | $54 | 5 Day Moving Average | $52.3(0.63%) | 10 Day Moving Average | $52.97(-0.64%) | 20 Day Moving Average | $54(-2.54%) | To recent high | -12% | To recent low | 4.3% | Market Cap | $26.851b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |